Developer docs
API playgroundTry for free, no card

Search company profiles

Cedars Sinai

Full company profile

uuid0000fe8

Namestring
Cedars Sinai
Legal namestring
Cedars-Sinai
Company typeenum
Private
Founded yearint
1902
Descriptiontext

Cedars-Sinai is a nonprofit academic medical center founded in 1902 and headquartered in Los Angeles, California, with more than 10,000 employees. The organization provides comprehensive healthcare services through its hospital, outpatient clinics, and AI-enabled virtual care platforms (including the Cedars-Sinai Connect app, in market since 2018 and used by 42,000+ patients), and serves as a clinical research and education institution via Cedars-Sinai Health Sciences University.

Its core technology stack is centered on an integrated AI ecosystem layered on top of the electronic health record: OpenEvidence enterprise for AI-powered clinical decision support, OpenAI ChatGPT for Healthcare for chart summarization and documentation, Regard for AI documentation, and EchoPrime — a proprietary video-based AI trained on over 12 million echocardiogram videos from 108,913 patients — for cardiology reporting. Adjacent capabilities include voice-enabled AI nurse documentation, continuous glucose monitor data integration, VR-based CBT therapy (XAIA), and robotic delivery via Moxi.

The business model is a fee-for-service and contract-based nonprofit health system that bills insurers, Medicare/Medicaid, and self-pay patients for clinical services, supplemented by grants (e.g., $5.3M Wellcome Trust), charitable financing schemes, and capital deployment through corporate venture investments. Go-to-market is hybrid: direct-to-consumer virtual care, enterprise AI and partnership deployments to other health systems (e.g., OpenAI's systemwide rollout to Cedars-Sinai among others), academic co-development (Caltech, Weizmann Institute), international clinical presence (Dubai via OMICS Precision Health), and high-profile event positioning (LA28 Olympic Games medical provider).

Short descriptiontext

Cedars-Sinai is a nonprofit academic medical center founded in 1902 in Los Angeles with 10,000+ employees, delivering comprehensive hospital, outpatient, and AI-enabled virtual care to patients while operating an integrated AI ecosystem spanning clinical decision support, documentation, and cardiac imaging.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hospital healthcare services, clinical decision support, virtual care platform, cardiac imaging AI, academic medical research
Industry3 codes
1Academic Medical Centers (AMCs) & Teaching Hospitals
CodeHLAFAAAAPrimaryYes
2Academic Medical Centers & Teaching Hospitals (University-Affiliated)
CodeEDAHAGAAPrimaryNo
3Urgent Care & On-Demand Virtual Visits
CodeHLALAAABPrimaryNo
NAICS code2 codes
  • General Medical and Surgical Hospitals6221
  • Other Outpatient Care Centers62149
SIC code2 codes
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Services-Hospitals8060
Product category
Academic Medical Center / Hospital Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Healthcare Services Revenue
TypeSubscription Recurring
Description

As a nonprofit hospital and health system, Cedars-Sinai generates revenue through providing medical services including hospital care, physician services, outpatient clinics, and virtual care. Revenue comes from patient services billed to insurance providers, Medicare, Medicaid, and self-pay patients.

cedars-sinai.org
2Charitable Financing Schemes
TypeSubscription Recurring
Description

Received nearly $28 million from a charity through California's recession-era financing scheme that involves fund redistribution from other hospitals in the state.

trib.al
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1Cedars-Sinai Connect
Description

AI-powered virtual care platform providing 24/7 care to patients

cedars-sinai.org
+1 more record
Core offering1 text field

Cedars-Sinai operates as a nonprofit academic medical center providing comprehensive hospital care, outpatient specialty services, and 24/7 virtual care to patients across Los Angeles and Southern California. Its portfolio is augmented by an integrated suite of AI-powered clinical tools—including EHR-integrated decision support (OpenEvidence), virtual urgent care (Cedars-Sinai Connect), cardiac imaging AI (EchoPrime), and automated documentation (Regard)—deployed to improve diagnostic accuracy, clinician efficiency, and patient outcomes.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • AI system provided more accurate diagnostic recommendations than physicians in 77% of virtual urgent care cases
+3 more records
Product overview1 text field

Cedars-Sinai Medical Center operates as a nonprofit hospital in Los Angeles offering comprehensive healthcare services alongside an expanding portfolio of AI-powered clinical tools. The core technology offerings include OpenEvidence Enterprise Platform for EHR-integrated clinical decision support, Cedars-Sinai Connect for 24/7 AI-powered virtual urgent care, EchoPrime for video-based cardiac imaging AI, and the Regard AI Documentation Platform. These products form an integrated AI ecosystem that spans clinical decision support, diagnostic imaging, virtual care delivery, and documentation automation. Additional offerings include the Cedars-Sinai Connect mobile app, the XAIA VR therapeutic program for mental health, Moxi delivery robots, and experimental space-grown heart organoids for research.

Product and service12 records
1OpenEvidence Enterprise Platform (deployed at Cedars-Sinai)
CategoryClinical decision support / AI platform
Description

AI-powered clinical decision support platform integrated into Cedars-Sinai's electronic health record (EHR) system that delivers real-time, patient-specific medical insights at the point of care by connecting clinicians with up-to-date peer-reviewed medical literature and clinical evidence.

2Cedars-Sinai Connect
CategoryVirtual care / Telehealth
Description

AI-powered 24/7 virtual urgent care platform that has served more than 42,000 patients since 2018, providing AI-assisted treatment recommendations and direct connections to Cedars-Sinai physicians.

3EchoPrime Cardiac AI
CategoryDiagnostic imaging AI
Description

Video-based AI system for analyzing echocardiogram footage and automatically generating cardiology reports; trained on over 12 million videos from 108,913 patients and outperforming existing models across 23 cardiac benchmarks.

4Regard AI Documentation Platform
CategoryClinical documentation AI
Description

AI-powered documentation platform that analyzes electronic health records to aid diagnostic accuracy and clinical note generation across multiple hospitals.

5XAIA Virtual Therapeutic Program
CategoryDigital therapeutics / Mental health
Description

Virtual reality program combined with GPT-4-based AI to deliver personalized cognitive behavioral therapy for patients with mild to moderate anxiety or depression.

6OpenAI for Healthcare (ChatGPT for Healthcare) at Cedars-Sinai
CategoryGenerative AI for clinical workflows
Description

HIPAA-compliant generative AI suite (powered by GPT-5.2) deployed at Cedars-Sinai Medical Center for patient chart summarization, clinical documentation drafting, and care coordination.

7Voice-Enabled AI Nurse Documentation Assistant
CategoryClinical documentation AI / Speech recognition
Description

Voice-enabled AI assistant using speech recognition for clinical documentation, piloted on a 48-bed surgical unit to reduce documentation time and cognitive load for nursing staff.

8Cedars-Sinai Connect Mobile App
CategoryVirtual care / Telehealth
Description

Mobile application enabling patients to connect with pediatric healthcare providers for urgent care needs via virtual consultations.

9Moxi Delivery Robot Service
CategoryHospital logistics robotics
Description

Healthcare delivery robot service that handles backend tasks such as moving linens and retrieving medications, freeing nurses and clinical staff to focus on direct patient care.

10Hospital and Specialty Clinical Services
CategoryHospital and specialty clinical services
Description

Comprehensive academic medical center services spanning hospital care, outpatient specialty clinics, cardiology, neurology, oncology, pediatrics, and surgical services for patients in the Los Angeles area and beyond.

11LA28 Olympic Games Medical Provider Services
CategorySports medicine / Event medical services
Description

Official medical provider services for the LA28 Olympic Games, providing medical advisement and treatment to athletes and delegations.

12Single-Cell Proteomics Research Program
CategoryTranslational research / Proteomics
Description

Investigator-led research program using single-cell proteomics technology to track proteins at the individual cell level, generating new insights into human body function and disease development.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-30
Description

Cedars-Sinai deployed OpenEvidence enterprise platform systemwide, integrating AI-powered clinical decision support tool directly into electronic health record system to provide real-time, patient-specific medical insights at point of care. Platform connects clinicians with up-to-date peer-reviewed medical literature and clinical evidence.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-21
Description

Cedars-Sinai expanding clinical, scientific, and educational partnerships with multiple healthcare institutions across Israel spanning cardiovascular medicine, digital health and AI-driven solutions, inflammatory bowel disease treatment programs, and stem cell research at International Space Station.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-14
Description

UCLA Health leading $9 million Parkinson's disease research project involving researchers from Cedars-Sinai, University of Münster, and University of Dundee.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-24
Description

Vast announced partnership with Cedars-Sinai for biomanufacturing research as part of commercial space station development including Haven-1.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-21
Description

Dr. Ravi Thadhani, Executive Vice President of Clinical Affairs and Chief Medical Officer at Cedars-Sinai, appointed to MyOme Board of Directors.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-03-12
Description

Cedars-Sinai and Select Medical, in collaboration with Dignity Health, hosting Soccer Medicine Conference on May 22, 2026 at Dignity Health Sports Park to share best practices in athlete care ahead of 2026 FIFA World Cup.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-14
Description

Cedars-Sinai Health Sciences University and Caltech launched partnership to advance scientific and academic achievements through joint translational discovery grants, co-hosted symposia, shared training opportunities, and joint faculty and student appointments. Combines Cedars-Sinai's clinical expertise with Caltech's strengths in engineering and computational sciences.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-02-11
Description

OMICS Precision Health launched healthspan-focused clinic in Dubai in collaboration with Cedars-Sinai, bringing advanced diagnostics and multi-omics analysis supported by Cedars-Sinai's global clinical expertise.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-01-14
Description

OpenAI launched ChatGPT for Healthcare with HIPAA-compliant AI suite, with Cedars-Sinai among major health systems deploying the technology for clinical workflows, documentation, and patient care support.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

SCAN Health Plan and Cedars-Sinai expanded partnership effective January 1, 2026 to improve healthcare access and coordination for older adults in Southern California, allowing SCAN members to access Cedars-Sinai hospitals and physicians.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-11-30
Description

K Health has strategic partnership with Cedars-Sinai for virtual healthcare access. Cedars-Sinai previously invested $59 million in a down round in 2023.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-11-06
Description

Amae Health partners with leading health systems including NewYork-Presbyterian, Cedars-Sinai, and Stanford Health Care for treatment of severe mental illness.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-10-21
Description

BriaCell Therapeutics added Cedars-Sinai Medical Center as clinical site in Phase 3 metastatic breast cancer study involving 79 sites.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-10-10
Description

Kneu Health raised $5.6 million seed funding co-led by Oxford Science Enterprises and Cedars-Sinai to expand precision neurology platform for Parkinson's and dementia management in the U.S.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-09-05
Description

Torrance Memorial expanding academic medical center ambitions through residency rotations in partnership with Cedars-Sinai.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UCLA Health is a Los Angeles-based academic medical center and the closest geographic and clinical peer to Cedars-Sinai, competing for complex tertiary care and research funding in the same Southern California market.

TypeDirect peer
Description

Stanford Health Care is a California academic medical center with comparable AI research initiatives (including OpenEvidence deployments) and overlapping specialty and concierge patient populations.

TypeDirect peer
Description

UCSF Health is a major California academic medical center deploying the same AI vendor stack (OpenEvidence, OpenAI for Healthcare) and competing for research grants, AI talent, and complex patient referrals.

TypeDirect peer
Description

Keck Medicine is a Los Angeles academic medical center and direct regional competitor for patients, faculty, and research collaborations within the same metro.

TypeDirect peer
Description

Mass General Brigham is a leading East Coast AMC and partner on Kneu Health; it competes with Cedars-Sinai in AI-driven neurology research and is a co-deployer of OpenEvidence.

TypeDirect peer
Description

NewYork-Presbyterian is a top-tier academic medical center that partners with Amae Health alongside Cedars-Sinai, and competes for tertiary referrals, AI pilots, and research talent.

TypeBroad incumbent
Description

Mayo Clinic is the largest nonprofit AMC system in the U.S. and a broader incumbent peer in clinical reputation, AI deployment, and international patient services.

TypeBroad incumbent
Description

Cleveland Clinic is a large, multi-state nonprofit AMC and broad peer in academic medicine, AI deployment, and complex specialty care delivery.

TypeDirect peer
Description

Northwestern Memorial Hospital and the Northwestern Medicine system are an AMC peer comparable in scale, AI investment posture, and urban academic care positioning.

TypeBroad incumbent
Description

HCA Healthcare is a large, multi-state hospital operator and broad incumbent peer in deploying OpenAI for Healthcare, representing competition in operational AI at scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability13 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment35 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cedars Sinai

Academic Medical Center / Hospital Servicescedars-sinai.org

Cedars-Sinai is a nonprofit academic medical center founded in 1902 in Los Angeles with 10,000+ employees, delivering comprehensive hospital, outpatient, and AI-enabled virtual care to patients while operating an integrated AI ecosystem spanning clinical decision support, documentation, and cardiac imaging.

What Cedars Sinai does

Cedars-Sinai is a nonprofit academic medical center founded in 1902 and headquartered in Los Angeles, California, with more than 10,000 employees. The organization provides comprehensive healthcare services through its hospital, outpatient clinics, and AI-enabled virtual care platforms (including the Cedars-Sinai Connect app, in market since 2018 and used by 42,000+ patients), and serves as a clinical research and education institution via Cedars-Sinai Health Sciences University.

Its core technology stack is centered on an integrated AI ecosystem layered on top of the electronic health record: OpenEvidence enterprise for AI-powered clinical decision support, OpenAI ChatGPT for Healthcare for chart summarization and documentation, Regard for AI documentation, and EchoPrime — a proprietary video-based AI trained on over 12 million echocardiogram videos from 108,913 patients — for cardiology reporting. Adjacent capabilities include voice-enabled AI nurse documentation, continuous glucose monitor data integration, VR-based CBT therapy (XAIA), and robotic delivery via Moxi.

The business model is a fee-for-service and contract-based nonprofit health system that bills insurers, Medicare/Medicaid, and self-pay patients for clinical services, supplemented by grants (e.g., $5.3M Wellcome Trust), charitable financing schemes, and capital deployment through corporate venture investments. Go-to-market is hybrid: direct-to-consumer virtual care, enterprise AI and partnership deployments to other health systems (e.g., OpenAI's systemwide rollout to Cedars-Sinai among others), academic co-development (Caltech, Weizmann Institute), international clinical presence (Dubai via OMICS Precision Health), and high-profile event positioning (LA28 Olympic Games medical provider).

Cedars Sinai firmographics

Firmographics
Name
Cedars Sinai
Legal name
Cedars-Sinai
Website
https://cedars-sinai.org
Company type
Private
Founded year
1902
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Cedars-Sinai is a nonprofit academic medical center founded in 1902 in Los Angeles with 10,000+ employees, delivering comprehensive hospital, outpatient, and AI-enabled virtual care to patients while operating an integrated AI ecosystem spanning clinical decision support, documentation, and cardiac imaging.
Ownership category
akta.pro rank

Cedars Sinai industry classification

Industry
Product category
Academic Medical Center / Hospital Services
NAICS
General Medical and Surgical Hospitals (6221), Other Outpatient Care Centers (62149)
SIC
Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)
akta.pro primary industry
Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)
akta.pro secondary industries
Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Urgent Care & On-Demand Virtual Visits (HLALAAAB)

Keywords

  • Hospital healthcare services
  • Clinical decision support
  • Virtual care platform
  • Cardiac imaging AI
  • Academic medical research

Where Cedars Sinai is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Cedars Sinai business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Healthcare Services Revenue: As a nonprofit hospital and health system, Cedars-Sinai generates revenue through providing medical services including hospital care, physician services, outpatient clinics, and virtual care. Revenue comes from patient services billed to insurance providers, Medicare, Medicaid, and self-pay patients.
  2. Charitable Financing Schemes: Received nearly $28 million from a charity through California's recession-era financing scheme that involves fund redistribution from other hospitals in the state.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Cedars Sinai product offering

Product offering

Core offering

Cedars-Sinai operates as a nonprofit academic medical center providing comprehensive hospital care, outpatient specialty services, and 24/7 virtual care to patients across Los Angeles and Southern California. Its portfolio is augmented by an integrated suite of AI-powered clinical tools—including EHR-integrated decision support (OpenEvidence), virtual urgent care (Cedars-Sinai Connect), cardiac imaging AI (EchoPrime), and automated documentation (Regard)—deployed to improve diagnostic accuracy, clinician efficiency, and patient outcomes.

Product overview

Cedars-Sinai Medical Center operates as a nonprofit hospital in Los Angeles offering comprehensive healthcare services alongside an expanding portfolio of AI-powered clinical tools. The core technology offerings include OpenEvidence Enterprise Platform for EHR-integrated clinical decision support, Cedars-Sinai Connect for 24/7 AI-powered virtual urgent care, EchoPrime for video-based cardiac imaging AI, and the Regard AI Documentation Platform. These products form an integrated AI ecosystem that spans clinical decision support, diagnostic imaging, virtual care delivery, and documentation automation. Additional offerings include the Cedars-Sinai Connect mobile app, the XAIA VR therapeutic program for mental health, Moxi delivery robots, and experimental space-grown heart organoids for research.

Differentiator

Problem solved

Functional benefit

Brands

  • Cedars-Sinai Connect: AI-powered virtual care platform providing 24/7 care to patients
  • Cedars-Sinai Health Sciences University

Products and services

  • OpenEvidence Enterprise Platform (deployed at Cedars-Sinai) AI-powered clinical decision support platform integrated into Cedars-Sinai's electronic health record (EHR) system that delivers real-time, patient-specific medical insights at the point of care by connecting clinicians with up-to-date peer-reviewed medical literature and clinical evidence.
  • Cedars-Sinai Connect AI-powered 24/7 virtual urgent care platform that has served more than 42,000 patients since 2018, providing AI-assisted treatment recommendations and direct connections to Cedars-Sinai physicians.
  • EchoPrime Cardiac AI Video-based AI system for analyzing echocardiogram footage and automatically generating cardiology reports; trained on over 12 million videos from 108,913 patients and outperforming existing models across 23 cardiac benchmarks.
  • Regard AI Documentation Platform AI-powered documentation platform that analyzes electronic health records to aid diagnostic accuracy and clinical note generation across multiple hospitals.
  • XAIA Virtual Therapeutic Program Virtual reality program combined with GPT-4-based AI to deliver personalized cognitive behavioral therapy for patients with mild to moderate anxiety or depression.
  • OpenAI for Healthcare (ChatGPT for Healthcare) at Cedars-Sinai HIPAA-compliant generative AI suite (powered by GPT-5.2) deployed at Cedars-Sinai Medical Center for patient chart summarization, clinical documentation drafting, and care coordination.
  • Voice-Enabled AI Nurse Documentation Assistant Voice-enabled AI assistant using speech recognition for clinical documentation, piloted on a 48-bed surgical unit to reduce documentation time and cognitive load for nursing staff.
  • Cedars-Sinai Connect Mobile App Mobile application enabling patients to connect with pediatric healthcare providers for urgent care needs via virtual consultations.
  • Moxi Delivery Robot Service Healthcare delivery robot service that handles backend tasks such as moving linens and retrieving medications, freeing nurses and clinical staff to focus on direct patient care.
  • Hospital and Specialty Clinical Services Comprehensive academic medical center services spanning hospital care, outpatient specialty clinics, cardiology, neurology, oncology, pediatrics, and surgical services for patients in the Los Angeles area and beyond.
  • LA28 Olympic Games Medical Provider Services Official medical provider services for the LA28 Olympic Games, providing medical advisement and treatment to athletes and delegations.
  • Single-Cell Proteomics Research Program Investigator-led research program using single-cell proteomics technology to track proteins at the individual cell level, generating new insights into human body function and disease development.

Quantifiable outcome

  • AI system provided more accurate diagnostic recommendations than physicians in 77% of virtual urgent care cases
  • +3 more outcomes

Companies that use Cedars Sinai

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Cedars Sinai technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability13 records

Feature7 records

Cedars Sinai partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered core and minor.

  • OpenEvidencecoreTechnology or Integration · 30 May 2026Cedars-Sinai deployed OpenEvidence enterprise platform systemwide, integrating AI-powered clinical decision support tool directly into electronic health record system to provide real-time, patient-specific medical insights at point of care. Platform connects clinicians with up-to-date peer-reviewed medical literature and clinical evidence.
  • Sheba Medical Center, Emek Medical Center, Assuta Ashdod Medical Center, Ichilov Hospital, Weizmann Institute of SciencecoreStrategic or Co-development Partner · 21 May 2026Cedars-Sinai expanding clinical, scientific, and educational partnerships with multiple healthcare institutions across Israel spanning cardiovascular medicine, digital health and AI-driven solutions, inflammatory bowel disease treatment programs, and stem cell research at International Space Station.
  • UCLA HealthminorStrategic or Co-development Partner · 14 May 2026UCLA Health leading $9 million Parkinson's disease research project involving researchers from Cedars-Sinai, University of Münster, and University of Dundee.
  • VastminorStrategic or Co-development Partner · 24 April 2026Vast announced partnership with Cedars-Sinai for biomanufacturing research as part of commercial space station development including Haven-1.
  • MyOmeminorStrategic or Co-development Partner · 21 April 2026Dr. Ravi Thadhani, Executive Vice President of Clinical Affairs and Chief Medical Officer at Cedars-Sinai, appointed to MyOme Board of Directors.
  • Select Medical and Dignity HealthminorStrategic or Co-development Partner · 12 March 2026Cedars-Sinai and Select Medical, in collaboration with Dignity Health, hosting Soccer Medicine Conference on May 22, 2026 at Dignity Health Sports Park to share best practices in athlete care ahead of 2026 FIFA World Cup.
  • CaltechcoreStrategic or Co-development Partner · 14 February 2026Cedars-Sinai Health Sciences University and Caltech launched partnership to advance scientific and academic achievements through joint translational discovery grants, co-hosted symposia, shared training opportunities, and joint faculty and student appointments. Combines Cedars-Sinai's clinical expertise with Caltech's strengths in engineering and computational sciences.
  • OMICS Precision HealthminorStrategic or Co-development Partner · 11 February 2026OMICS Precision Health launched healthspan-focused clinic in Dubai in collaboration with Cedars-Sinai, bringing advanced diagnostics and multi-omics analysis supported by Cedars-Sinai's global clinical expertise.
  • OpenAIcoreTechnology or Integration · 14 January 2026OpenAI launched ChatGPT for Healthcare with HIPAA-compliant AI suite, with Cedars-Sinai among major health systems deploying the technology for clinical workflows, documentation, and patient care support.
  • SCAN Health PlancoreStrategic or Co-development Partner · 1 January 2026SCAN Health Plan and Cedars-Sinai expanded partnership effective January 1, 2026 to improve healthcare access and coordination for older adults in Southern California, allowing SCAN members to access Cedars-Sinai hospitals and physicians.
  • K HealthminorStrategic or Co-development Partner · 30 November 2025K Health has strategic partnership with Cedars-Sinai for virtual healthcare access. Cedars-Sinai previously invested $59 million in a down round in 2023.
  • Amae HealthminorStrategic or Co-development Partner · 6 November 2025Amae Health partners with leading health systems including NewYork-Presbyterian, Cedars-Sinai, and Stanford Health Care for treatment of severe mental illness.
  • BriaCell TherapeuticsminorStrategic or Co-development Partner · 21 October 2025BriaCell Therapeutics added Cedars-Sinai Medical Center as clinical site in Phase 3 metastatic breast cancer study involving 79 sites.
  • Kneu HealthminorStrategic or Co-development Partner · 10 October 2025Kneu Health raised $5.6 million seed funding co-led by Oxford Science Enterprises and Cedars-Sinai to expand precision neurology platform for Parkinson's and dementia management in the U.S.
  • Torrance MemorialminorStrategic or Co-development Partner · 5 September 2025Torrance Memorial expanding academic medical center ambitions through residency rotations in partnership with Cedars-Sinai.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Cedars Sinai competitors and assessment

Company assessment

Direct peers

  • UCLA Health: UCLA Health is a Los Angeles-based academic medical center and the closest geographic and clinical peer to Cedars-Sinai, competing for complex tertiary care and research funding in the same Southern California market.
  • Stanford Health Care: Stanford Health Care is a California academic medical center with comparable AI research initiatives (including OpenEvidence deployments) and overlapping specialty and concierge patient populations.
  • UCSF Health: UCSF Health is a major California academic medical center deploying the same AI vendor stack (OpenEvidence, OpenAI for Healthcare) and competing for research grants, AI talent, and complex patient referrals.
  • Keck Medicine of USC: Keck Medicine is a Los Angeles academic medical center and direct regional competitor for patients, faculty, and research collaborations within the same metro.
  • Mass General Brigham: Mass General Brigham is a leading East Coast AMC and partner on Kneu Health; it competes with Cedars-Sinai in AI-driven neurology research and is a co-deployer of OpenEvidence.
  • NewYork-Presbyterian: NewYork-Presbyterian is a top-tier academic medical center that partners with Amae Health alongside Cedars-Sinai, and competes for tertiary referrals, AI pilots, and research talent.
  • Northwestern Medicine: Northwestern Memorial Hospital and the Northwestern Medicine system are an AMC peer comparable in scale, AI investment posture, and urban academic care positioning.

Broad incumbents

  • Mayo Clinic: Mayo Clinic is the largest nonprofit AMC system in the U.S. and a broader incumbent peer in clinical reputation, AI deployment, and international patient services.
  • Cleveland Clinic: Cleveland Clinic is a large, multi-state nonprofit AMC and broad peer in academic medicine, AI deployment, and complex specialty care delivery.
  • HCA Healthcare: HCA Healthcare is a large, multi-state hospital operator and broad incumbent peer in deploying OpenAI for Healthcare, representing competition in operational AI at scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Cedars Sinai social profiles

Digital presence

Cedars Sinai financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cedars Sinai leadership team

Management profile

Number of profiles

Profiles14 records

Cedars Sinai funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cedars Sinai M&A and investment

M&A and investment

M&A

Investments35 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cedars Sinai

What does Cedars Sinai do?

Cedars-Sinai operates as a nonprofit academic medical center providing comprehensive hospital care, outpatient specialty services, and 24/7 virtual care to patients across Los Angeles and Southern California. Its portfolio is augmented by an integrated suite of AI-powered clinical tools—including EHR-integrated decision support (OpenEvidence), virtual urgent care (Cedars-Sinai Connect), cardiac imaging AI (EchoPrime), and automated documentation (Regard)—deployed to improve diagnostic accuracy, clinician efficiency, and patient outcomes.

Is Cedars Sinai a public or private company?

Cedars Sinai is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Cedars Sinai founded?

Cedars Sinai was founded in 1902. It employs 5,001 to 10,000 people.

Where is Cedars Sinai based?

Cedars Sinai is headquartered in Los Angeles, United States, in the North America region.

How does Cedars Sinai make money?

Two revenue lines are on record. Healthcare Services Revenue is the primary driver. The others are charitable Financing Schemes.

Who are Cedars Sinai's main competitors?

Direct peers on record are UCLA Health, Stanford Health Care, UCSF Health, Keck Medicine of USC, Mass General Brigham, NewYork-Presbyterian and Northwestern Medicine. Broad incumbents are Mayo Clinic, Cleveland Clinic and HCA Healthcare.

Does Cedars Sinai have an API?

No public API is recorded for Cedars Sinai.

What industry is Cedars Sinai in?

Cedars Sinai's product category is Academic Medical Center / Hospital Services. Its primary akta.pro industry code is HLAFAAAA, Academic Medical Centers (AMCs) & Teaching Hospitals, with a secondary code of EDAHAGAA, Academic Medical Centers & Teaching Hospitals (University-Affiliated). Its NAICS code is 6221 and its SIC code is 8062.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooChristian Koloko suffered from venous thoracic outlet syndrome during rookie season in TorontoChristian Koloko was diagnosed with venous thoracic outlet syndrome during his rookie season in Toronto. Cedars-Sinai doctors found his left arm was three centimeters larger than his right and a major clot in the vein draining it. The diagnosis was confirmed via venogram.MedicalxpressSmall bowel microbiome offers clues to women's healthInvestigators at Cedars-Sinai Health Sciences University have identified distinct differences in the small bowel microbiome between men and women, highlighting biological sex as a critical variable in digestive health. The study found a specific bacterial community containing Granulicatella present only in women, which appears at increased levels in those with polycystic ovary syndrome. These findings suggest that considering sex-specific microbial profiles is essential for developing personalized approaches to treating diseases such as irritable bowel syndrome.Beckershospitalreview4 health systems’ 1 condition for ChatGPT for Healthcare’s Epic integrationOpenAI added an Epic EHR integration to its ChatGPT healthcare platform, with UCSF Health as pilot. Health systems require traceable, auditable outputs and clinician verification before adoption. Cedars-Sinai, Nationwide Children's, and Penn Medicine each outlined their own safeguards or existing tools.Cedars-sinaiArt in Healthcare at Cedars-Sinai Marina HospitalCedars-Sinai unveiled a 120-foot-wide, 16-foot-tall mosaic mural on the façade of its new Marina del Rey hospital. Designed by artist Jay Yan, the sunburst reflects the Marina sky and honors the tile artisans from Guadalajara. The hospital's operations chief expects the art to instill pride and provide healing for patients.Cedars-sinaiSpectrum News 1: Cedars-Sinai Surgeons Embrace the Power of Robot-Assisted SurgeriesCedars-Sinai surgeons performed the hospital's first robot-assisted microsurgery for lymphedema, using a robotic system to reduce hand tremors and improve precision. The procedure, which aids patients after cancer treatment, is expected to become more common, with residents and fellows being trained to incorporate the technology.GurufocusEmmaus Life Sciences Announces Agreement for Evaluation of L-gluEmmaus Life Sciences entered an exclusive option agreement with Cedars-Sinai to investigate L-glutamine oral powder with chemotherapy for pancreatic ductal adenocarcinoma. The research follows the GlutaPanc trial results published in Nature Cancer, and no regulatory approval is guaranteed.YahooEmmaus Life Sciences Announces Agreement for Evaluation of L-glutamine for Pancreatic CancerEmmaus Life Sciences entered an exclusive option agreement with Cedars-Sinai to investigate L-glutamine oral powder with chemotherapy for pancreatic ductal adenocarcinoma. The research follows the GlutaPanc trial results published in Nature Cancer, and safety and efficacy have not been established.Stock TitanEmmaus Enters Exclusive Pancreatic Cancer Drug OptionEmmaus Life Sciences entered an exclusive option agreement with Cedars-Sinai to investigate L-glutamine oral powder with chemotherapy for pancreatic ductal adenocarcinoma. The research follows the GlutaPanc trial results published in Nature Cancer. The company stated no guarantee of regulatory approval for this investigational use.BioSpaceEmmaus Life Sciences Announces Agreement for Evaluation of L-glutamine for Pancreatic CancerEmmaus Life Sciences entered an exclusive option agreement with Cedars-Sinai to investigate L-glutamine oral powder with chemotherapy for pancreatic ductal adenocarcinoma. The research follows the GlutaPanc trial results published in Nature Cancer, and no safety or efficacy has been established for this use.AETOSWireEmmaus Life Sciences Announces Agreement for Evaluation of L-glutamine for Pancreatic CancerEmmaus Life Sciences entered an exclusive option agreement with Cedars-Sinai to investigate L-glutamine oral powder with chemotherapy for pancreatic ductal adenocarcinoma. The research follows the GlutaPanc trial results published in Nature Cancer. The company stated no guarantee of regulatory approval for this investigational use.